RNA · Atrium Therapeutics, Inc. · Proposed Sales
$8.25
+0.20 (+2.48%)
At close · Oct 27
Return incl. dividend (before tax)
Market Cap
$137.70M
Shares
17.11M
Volume · Oct 27
78.74K
Avg daily vol (3M)
264.95K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
2093101
CUSIP
04965N104
13F (30d)
13 filings
13 filers
Visit website
Investor relations